(N-(3-(4-(4-(8-Oxo-8H-(1,3)-dioxolo-(4,5-g)-chromen-7-yl)-butyl)-piperazin-1-yl)-phenyl)-methanesulfonamide, hydrochloride) - CISMeF

" /> (N-(3-(4-(4-(8-Oxo-8H-(1,3)-dioxolo-(4,5-g)-chromen-7-yl)-butyl)-piperazin-1-yl)-phenyl)-methanesulfonamide, hydrochloride) - CISMeF

CISMeF

chu

(N-(3-(4-(4-(8-Oxo-8H-(1,3)-dioxolo-(4,5-g)-chromen-7-yl)-butyl)-piperazin-1-yl)-phenyl)-methanesulfonamide, hydrochloride)MeSH concept

Preferred Label : (N-(3-(4-(4-(8-Oxo-8H-(1,3)-dioxolo-(4,5-g)-chromen-7-yl)-butyl)-piperazin-1-yl)-phenyl)-methanesulfonamide, hydrochloride);

Details

Origin ID

M000749823;

Related record
- dopamine D3 receptor antagonist F17464 [MeSH Supplementary Concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients

Nous contacter.
03/05/2025

© Rouen University Hospital. Any partial or total use of this material must mention the source.